SCHEMBL21907353

SCHEMBL21907353

CSOCc1cnc(Oc2ccc(Cl)cc2F)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRB P28702 5/20 0.46
KCNH2 Q12809 3/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.38
S1PR4 O95977 1/20 0.37
MEN1 O00255 1/20 0.35
PKM P14618 1/20 0.35
KMT2A Q03164 1/20 0.35
PTGER1 P34995 4/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
TBXA2R P21731 2/20 0.34
PTGS1 P23219 2/20 0.34
CYP2C19 P33261 2/20 0.34
PTGER3 P43115 2/20 0.34
PTGER2 P43116 2/20 0.34
GHSR Q92847 2/20 0.34
MRGPRX4 Q96LA9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21906532 0.88 RXRB (0.45) RXRB
SCHEMBL21907351 0.82 MEN1 (0.47) RXRBL3MBTL1MEN1KMT2ACYP1A2
SCHEMBL21907354 0.81 RXRB (0.47) RXRBKCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL21906515 0.81 RXRB (0.50) RXRBKCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL21906702 0.79 HTT (0.42) RXRBL3MBTL1MEN1KMT2ACYP1A2
SCHEMBL21906696 0.77 HTT (0.47) RXRBSLC6A2SLC6A4SLC6A3L3MBTL1
SCHEMBL21906498 0.74 L3MBTL1 (0.44) RXRBL3MBTL1MEN1KMT2ACYP1A2
SCHEMBL21906688 0.69 RXRB (0.47) RXRBKCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL23380132 0.68 L3MBTL1 (0.44) RXRBKCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL21902703 0.68 ALDH1A1 (0.54) RXRBKCNH2SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3867244-B1 4-PYRAZIN-2-YLMETHYL-MORPHOLINE DERIVATIVES AND THE USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM INT (DE) 2023-01-18 EP disclosed
WO-2020079039-A1 4-PYRAZIN-2-YLMETHYL-MORPHOLINE DERIVATIVES AND THE USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2020-04-23 WO disclosed